Psychosocial Interventions for Bipolar Disorder: A Review of Literature and Introduction of the Systematic Treatment Enhancement Program
David J. Miklowitz, PhD and Michael W. Otto, PhD
-
The Emergence of the Bipolar Spectrum: Validation along Clinical-Epidemiologic and Familial-Genetic Lines
Hagop S. Akiskal, MD
-
Pharmacotherapy of Neuropsychiatric Syndromes in Neurologic Disorders: Definitional and Regulatory Aspects
Jeffrey L. Cummings, MD and Dilip V. Jeste, MD
-
Cognitive Behavioral Approaches to the Treatment of Pain
Sandra J. Waters, PhD, Daphne C. McKee, PhD, and Francis J. Keefe, PhD
-
Invited Commentary: Understanding the Fibromyalgia Syndrome
I. Jon Russell, MD, PhD. and Christopher J. Wohlberg, MD, PhD
-
Evidence-Based Treatment of Psychiatric Disorders with Comorbid Medical Illnesses: The Need for Large Simple Clinical Trials
Warren D. Taylor, MD, P. Murali Doraiswamy, M.B.,B.S., and K. Ranga R. Krishnan, M.B.,B.S
-
Panel Discussion
-
Drug Development for Anxiety Disorders: New Roles for Atypical Antipsychotics
By William H. Carson, MD, Hisashi Kitagawa, PhD, and Charles B. Nemeroff, MD, PhD
-
Unmet Needs in the Treatment of Anxiety Disorders
By Mark H. Pollack, MD
-
Late-Life Anxiety Disorders
By Carl Salzman, MD
-
Understanding Psychiatric Disorders Through Functional Brain Imaging
By Clinton D. Kilts, PhD
-
Early-Life Adversity, CRF Dysregulation, and Vulnerability to Mood and Anxiety Disorders
By Charles B. Nemeroff, MD, PhD
-
Studying Non-Human Primates: A Gateway to Understanding Anxiety Disorders
By Ned H. Kalin, MD
-
Advancing the Treatment of Anxiety Disorders: New Findings and Novel Uses for Atypical Antipsychotics
By Charles B. Nemeroff, MD, PhD
-
-
FEATURE ARTICLE
Understanding The Fibromyalgia Syndrome
Srinivas G. Rao, MD, PhD, Judith F. Gendreau, MD, and Jay D. Kranzler, MD, PhD
-
Valproate Use in Neuropsychiatric Disorders in the Elderly
By Pierre N. Tariot, MD
-
Divalproex in the Treatment of Migraine
By Frederick G. Freitag, DO
-
The Use of Divalproex in the Treatment of Addictive Disorders
By Hugh Myrick, MD and Kathleen T. Brady, MD, PhD
-
Schizophrenia and Valproate
By Leslie Citrome, MD, MPH
-
Divalproex in the Treatment of Bipolar Disorder
By Paul E. Keck, Jr, MD, and Susan L. McElroy, MD
-
The Efficacy of Divalproex for Partial Epilepsies
By Michael C. Smith, MD
-
Divalproex and Epilepsy
By L. James Willmore, MD
-
Pharmacokinetics, Drug Interactions, and Tolerability of Valproate
By C. Lindsay DeVane, PharmD
-
Pharmacology of Valproate
By Michael J. Owens, PhD, and Charles B. Nemeroff, MD, PhD
-
The History of Valproate in Clinical Neuroscience
By Thomas R. Henry, MD
-
Efficacy and Tolerability of Controlled-Release Paroxetine
By Robert N. Golden, MD
-
Paroxetine Treatment of Mood and Anxiety Disorders in Children and Adolescents
By Karen Dineen Wagner, MD, PhD
-
Clinical Management of Perinatal Depression: Focus on Paroxetine
By D. Jeffrey Newport, MD, MSCR, MDiv, and Zachary N. Stowe, MD
-
Paroxetine Treatment of Mood Disorders in Women: Premenstrual Dysphoric Disorder and Hot Flashes
By Kimberly A. Yonkers, MD
-
Paroxetine Treatment of Depression in Late Life
By Charles F. Reynolds III, MD
-
Paroxetine Use in Medically Ill Patients
By Steven Stout, MD, PhD, Wendy I. Somerset, MD, Andrew Miller, MD, and Dominique L. Musselman, MD, MS
-
Advances in Recognition and Treatment of Social Anxiety Disorder: A 10-Year Retrospective
By Murray B. Stein, MD, FRCPC
-
Obsessive-Compulsive Disorder: Implications of the Efficacy of an SSRI, Paroxetine
By Philip T. Ninan, MD
-
Treatment of Posttraumatic Stress Disorder: The Impact of Paroxetine
By Jonathan R.T. Davidson, MD
-
Paroxetine Treatment of Generalized Anxiety Disorder
By David V. Sheehan, MD, MBA, and C. Gloria Mao, PharmD
-
Treatment of Panic Disorder: Focus on Paroxetine
By Mark H. Pollack, MD and Alicia C. Doyle, BA
-
Paroxetine Treatment of Major Depressive Disorder
By Martin B. Keller, MD
-
Pharmacokinetics, Drug Interactions, and Tolerability of Paroxetine and Paroxetine CR
By C. Lindsay DeVane, PharmD
-
In Vivo Neuroimaging Correlates of the Efficacy of Paroxetine in the Treatment of Mood and Anxiety Disorders
By Clinton Kilts, PhD
